McLean Hospital
McLean Hospital, an affiliate of Harvard Medical School and Massachusetts General Hospital and a member of Partners HealthCare, Inc., is a comprehensive healthcare system providing mental health services in the Boston area and beyond. Since 1811, McLean Hospital has been a world leader in the treatment of mental illness and chemical dependency, research into the cause of mental illness, and the training of generations of mental health care providers. Today, with external research funding of almost $50 million annually, McLean investigators conduct both clinical and preclinical research in which many of the techniques of modern medicine, molecular biology and imaging are brought to bear on important problems in psychiatry and neurological disorders. More information on McLean’s research activities can be found at – McLean Hospital
Innovations (46):
- Generation of iPS Cells by Direct Protein Delivery (18 MAY 11)
- Methods for the Diagnosis and Treatment of Parkinson's Disease (18 MAY 11)
- Salvinorin Compounds and Uses Thereof (18 MAY 11)
- Modified Apomorphine Derivatives (18 MAY 11)
- Implantable Electroconvulsive Therapy (18 MAY 11)
- Drug-Enhanced Neurofeedback Using Functional Magnetic Resonance Imaging (18 MAY 11)
- Analyzing the Prosody of Speech (20 JAN 11)
- Blood Test for Diagnosis and Prognosis of Bipolar Disorder (20 JAN 11)
- Systems and Methods for Identification of Autism and Other Disorders (20 JAN 11)
- Cell-Specific Enhancer Domains for Neuronal Gene Expression (04 MAR 09)
Find more innovations
